Tumor Lysis Syndrome [syndrom nádorového rozpadu]

topical
38
Terms

syndrom lýzy nádoru
syndrom lýzy tumoru
syndrom nádorové lýzy

 

Tumour Lysis Syndrome

Persistent link   https://www.medvik.cz/link/D015275
Definition

A syndrome resulting from cytotoxic therapy, occurring generally in aggressive, rapidly proliferating lymphoproliferative disorders. It is characterized by combinations of hyperuricemia, lactic acidosis, hyperkalemia, hyperphosphatemia and hypocalcemia.

Annotation
lymphoproliferative disord caused by anticancer drugs; coord IM with /etiol (not /chem ind) + anticancer drug /adv eff (IM) + required neopl coords /drug ther (IM or NIM) if pertinent
DUI
D015275 MeSH Browser
CUI
M0023515
Previous indexing
Antineoplastic Agents, Combined/adverse effects/therapeutic use (1980-1988); Antineoplastic Agents/therapeutic use (1984-1988); Burkitt's Lymphoma/complications (1980-1988)
History note
89
Public note
89

C Diseases
C15.604.515.032 Agammaglobulinemia 113
C15.604.515.245 Castleman Disease 61
C15.604.515.292 Granuloma 236
C15.604.515.435 Heavy Chain Disease 8
C15.604.515.516 Infectious Mononucleosis 191
C15.604.515.553 Leukemia, Hairy Cell 95
C15.604.515.560 Leukemia, Lymphoid 477
C15.604.515.562 Lymphangiomyoma 1
C15.604.515.569 Lymphoma 1 119
C15.604.515.700 Marek Disease 7
C15.604.515.827 Sarcoidosis 500
C15.604.515.841 Sezary Syndrome 43
C15.604.515.880 Tumor Lysis Syndrome 38
C20.683.515.250 Castleman Disease 61
C20.683.515.515 Infectious Mononucleosis 191
C20.683.515.517 Leukemia, Hairy Cell 95
C20.683.515.528 Leukemia, Lymphoid 477
C20.683.515.710 Lymphangiomyoma 1
C20.683.515.761 Lymphoma 1 119
C20.683.515.840 Marek Disease 7
C20.683.515.845 Multiple Myeloma 1 782
C20.683.515.880 Plasmacytoma 179
C20.683.515.920 Sezary Syndrome 43
C20.683.515.950 Tumor Lysis Syndrome 38